歐洲蛋白質定序市場按應用、最終用戶和國家分類 - 分析和預測（2024-2033）

預計到 2033 年，歐洲蛋白質定序市場規模將從 2024 年的 4.772 億美元增至 6.856 億美元，2024-2033 年預測期內的複合年成長率為 4.11%。

蛋白質定序是確定蛋白質中胺基酸的精確順序的過程，對於了解蛋白質的結構、功能和在生物系統中的作用至關重要。它們在生物技術、生物醫學研究、藥物發現和疾病診斷中發揮關鍵作用，並為精準醫療和標靶治療的進步做出了重大貢獻。蛋白質定序為轉譯後修飾、蛋白質相互作用和疾病機制提供了寶貴的見解，有助於生命科學和醫療保健領域的突破。

在歐洲，由於對蛋白質體學研究的投入不斷增加、生物製藥行業的不斷擴張以及個人化醫療的需求不斷增加，蛋白質定序的採用正在加速。兩種主要的定序技術分別是對小蛋白質有效的Edman分解技術和因高通量和分析複雜樣本的能力而被廣泛用於大規模蛋白質體學的質譜技術。市場包括促進定序過程的儀器、試劑和消耗品，以及提供專業定序服務的受託研究機構。

對生物標記發現、藥物開發和疾病診斷的需求不斷成長，推動著蛋白質定序技術的不斷創新。在政府的大力支持、不斷增加的私人投資和強大的研究生態系統的幫助下，歐洲在蛋白質組學和基於蛋白質的研究方面有望實現顯著成長。

歐洲蛋白質定序市場正在穩步成長，這得益於蛋白質組學研究的投資增加、生物製藥行業的不斷擴張以及個人化醫療需求的不斷成長。蛋白質定序可以確定蛋白質中胺基酸的精確順序，對於了解蛋白質的結構、功能和相互作用至關重要。它們在藥物發現、疾病診斷和生物標記識別中發揮關鍵作用，支持精準醫療和標靶治療的進步。

市場發展主要受到質譜和 Edman 分解等定序技術的進步的推動。質譜法因其能夠有效分析複雜的蛋白質樣本而廣泛應用於高通量蛋白質體學，而埃德曼分解法對於較小蛋白質的序列測定仍具有相關性。在歐洲，在政府資助以及研究機構、製藥和生物技術公司之間的合作的推動下，對創新的高度重視正在刺激該領域的進一步發展。

推動市場成長的關鍵因素包括腫瘤學、神經退化性疾病和感染疾病研究領域的應用不斷擴大。此外，人工智慧和機器學習擴大被應用於蛋白質組學以增強資料分析能力。憑藉成熟的研究生態系統和不斷成長的生命科學投資，歐洲蛋白質定序市場有望實現長期擴張，並將塑造蛋白質組學和生物醫學研究的未來。

本報告研究了歐洲蛋白質定序市場，並提供了市場概述、應用、最終用戶和國家/地區趨勢以及參與市場的公司概況。

目錄

執行摘要

第 1 章歐洲蛋白質定序市場概述

• 趨勢：當前和未來的影響評估
• 蛋白質序列測定工作流程
• 法律規範
• 市場動態概覽

2. 蛋白質定序市場（按地區分類），百萬美元，2022-2033 年

• 區域摘要
• 歐洲
  • 區域概況
  • 市場成長動力
  • 成長抑制因素
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 其他

第3章 市場-競爭格局

• 歐洲蛋白質定序市場：競爭格局
  • 企業策略 2021 年 1 月 - 2024 年 9 月
  • 夥伴關係、合作和業務擴展
• 公司簡介
  • Merck KGaA
  • Proteome Factory AG
  • Selvita SA

第4章調查方法

Introduction to Europe Protein Sequencing Market

The Europe protein sequencing market is projected to reach $685.6 million by 2033 from $477.2 million in 2024, growing at a CAGR of 4.11% during the forecast period 2024-2033. Protein sequencing is the process of determining the precise order of amino acids in a protein, essential for understanding its structure, function, and role in biological systems. It plays a crucial role in biotechnology, biomedical research, drug discovery, and disease diagnostics, significantly contributing to advancements in precision medicine and targeted therapies. Protein sequencing provides valuable insights into post-translational modifications, protein interactions, and disease mechanisms, supporting breakthroughs in life sciences and healthcare.

In Europe, the adoption of protein sequencing is accelerating, driven by growing investments in proteomics research, the expansion of the biopharmaceutical industry, and increasing demand for personalized medicine. The two primary sequencing techniques are Edman degradation, which is effective for smaller proteins, and mass spectrometry, widely used for large-scale proteomics due to its high throughput and ability to analyze complex samples. The market comprises instruments, reagents, and consumables that facilitate sequencing processes, alongside contract research organizations providing specialized sequencing services.

Rising demand for biomarker discovery, drug development, and disease diagnostics is driving continuous innovation in protein sequencing technologies. With strong government support, increasing private-sector investments, and a robust research ecosystem, Europe is poised for significant growth in proteomics and protein-based research.

Market Introduction

The Europe protein sequencing market is experiencing steady growth, driven by increasing investments in proteomics research, expanding biopharmaceutical industries, and the rising demand for personalized medicine. Protein sequencing, which determines the precise order of amino acids in a protein, is essential for understanding protein structures, functions, and interactions. It plays a crucial role in drug discovery, disease diagnostics, and biomarker identification, supporting advancements in precision medicine and targeted therapies.

The market is primarily driven by advancements in sequencing technologies such as mass spectrometry and Edman degradation. Mass spectrometry is widely used for high-throughput proteomics due to its ability to analyze complex protein samples efficiently, while Edman degradation remains relevant for sequencing smaller proteins. Europe's strong focus on innovation, supported by government funding and collaborations between research institutions, pharmaceutical companies, and biotechnology firms, is fostering further developments in this field.

Key factors propelling market growth include increasing applications in oncology, neurodegenerative diseases, and infectious disease research. Additionally, the rising adoption of artificial intelligence and machine learning in proteomics is enhancing data analysis capabilities. With a well-established research ecosystem and growing investments in life sciences, the European protein sequencing market is poised for long-term expansion, shaping the future of proteomics and biomedical research.

Market Segmentation:

Segmentation 1: By Application

• Biotherapeutics
• Genetic Engineering
• Others

Segmentation 2: By End User

• Academic Institutes
• Pharma and CROs
• Biotech, Diagnostics, and Other Companies

Segmentation 3: By Region

• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest-of-Europe

How can this report add value to an organization?

Product/Innovation Strategy: The report offers in-depth insights into the latest technological advancements and emerging applications in protein sequencing, enabling organizations to drive innovation and develop cutting-edge products tailored to market needs.

Growth/Marketing Strategy: By providing comprehensive market analysis and identifying key growth opportunities, the report equips organizations with the knowledge to craft targeted marketing strategies and expand their market presence effectively.

Competitive Strategy: The report includes a thorough competitive landscape analysis, helping organizations understand their competitors' strengths and weaknesses and allowing them to strategize effectively to gain a competitive edge in the market.

Key Market Players and Competition Synopsis

Profiled companies have been selected based on inputs gathered from primary experts, as well as analyzing company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

• Selvita
• Merck KGaA
• Proteome Factory AG

Table of Contents

Executive Summary

Scope and Definition

1 Europe Protein Sequencing Market: Overview

• 1.1 Trends: Current and Future Impact Assessment
  • 1.1.1 Increasing Product Launches in the Market
  • 1.1.2 Growing Adoption of Single-Molecule Protein Sequencing
  • 1.1.3 High Demand for Biologics Development
• 1.2 Workflow of Protein Sequencing
  • 1.2.1 Protein Sequencing Workflow Overview
• 1.3 Regulatory Framework
  • 1.3.1 European Union (EU)
    • 1.3.1.1 Regulatory Requirements for Protein Sequencing Products Intended as Medical Devices
      • 1.3.1.1.1 EU Medical Device Regulation
      • 1.3.1.1.2 EU In Vitro Diagnostic Regulation
    • 1.3.1.2 Regulatory Requirements for Clinical Protein Sequencing

Labs in the EU 26

• 1.4 Patent Analysis
  • 1.4.1 Patent Filing Trend (by Country)
  • 1.4.2 Patent Filing Trend (by Year)
• 1.5 Market Dynamics Overview
  • 1.5.1 Market Drivers
    • 1.5.1.1 Advancements in Computational Biology and Bioinformatics in the Europe Protein Engineering Market
    • 1.5.1.2 Expanding Applications in Research
    • 1.5.1.3 Technological Advancements in Protein Sequencing
  • 1.5.2 Market Restraints
    • 1.5.2.1 Shortage of Skilled Labour
    • 1.5.2.2 High Cost Hindering the Adoption of Protein Sequencing
  • 1.5.3 Market Opportunities
    • 1.5.3.1 Integration of Artificial Intelligence in Protein Sequencing

2 Protein Sequencing Market (By Region), $Million, 2022-2033

• 2.1 Regional Summary
• 2.2 Europe
  • 2.2.1 Regional Overview
  • 2.2.2 Driving Factors for Market Growth
  • 2.2.3 Factors Challenging the Market
  • 2.2.4 Germany
  • 2.2.5 U.K.
  • 2.2.6 France
  • 2.2.7 Italy
  • 2.2.8 Spain
  • 2.2.9 Rest-of-Europe

3 Markets - Competitive Landscape

• 3.1 Europe Protein Sequencing Market: Competitive Landscape
  • 3.1.1 Corporate Strategies, January 2021-September 2024
  • 3.1.2 Partnerships, Alliances, and Business Expansions
• 3.2 Company Profiles
  • 3.2.1 Merck KGaA
    • 3.2.1.1 Overview
    • 3.2.1.2 Top Products
    • 3.2.1.3 Top Competitors
    • 3.2.1.4 Target Customers/End Users
    • 3.2.1.5 Analyst View
  • 3.2.2 Proteome Factory AG
    • 3.2.2.1 Overview
    • 3.2.2.2 Services Offered
    • 3.2.2.3 Top Competitors
    • 3.2.2.4 Target Customers/End Users
    • 3.2.2.5 Analyst View
  • 3.2.3 Selvita S.A.
    • 3.2.3.1 Overview
    • 3.2.3.2 Services Offered
    • 3.2.3.3 Top Competitors
    • 3.2.3.4 Target Customers/End Users
    • 3.2.3.5 Analyst View

4 Research Methodology

• 4.1 Data Sources
  • 4.1.1 Primary Data Sources
  • 4.1.2 Secondary Data Sources
  • 4.1.3 Data Triangulation
• 4.2 Market Estimation and Forecast

List of Figures

• Figure 1: Europe Protein Sequencing Market, $Million, 2024, 2028, and 2033
• Figure 2: Protein Sequencing Market (by Region), $Million, 2023, 2027, and 2033
• Figure 3: Europe Protein Sequencing Market (by Application), $Million, 2023, 2027, and 2033
• Figure 4: Europe Protein Sequencing Market (by End User), $Million, 2023, 2027, and 2033
• Figure 5: Key Events to Keep Track of in the Protein Sequencing Market
• Figure 6: Protein Sequencing Workflow Overview
• Figure 7: Number of Protein Sequencing Patents (by Country), January 2019-May 2024
• Figure 8: Number of Protein Sequencing Patents (by Year), January 2019-May 2024
• Figure 9: Impact Analysis of Market Navigating Factors, 2022-2033
• Figure 10: Germany Protein Sequencing Market, $Million, 2022-2033
• Figure 11: U.K. Protein Sequencing Market, $Million, 2022-2033
• Figure 12: France Protein Sequencing Market, $Million, 2022-2033
• Figure 13: Italy Protein Sequencing Market, $Million, 2022-2033
• Figure 14: Spain Protein Sequencing Market, $Million, 2022-2023
• Figure 15: Rest-of-Europe Protein Sequencing Market, $Million, 2022-2033
• Figure 16: Corporate Strategies, January 2021- September 2024
• Figure 17: Data Triangulation
• Figure 18: Top-Down and Bottom-Up Approach
• Figure 19: Assumptions and Limitations

List of Tables

• Table 1: Market Snapshot
• Table 2: Europe Protein Sequencing Market Opportunities
• Table 3: Product Launches, January 2023-September 2024
• Table 4: Companies Providing Single-Molecule Protein Sequencing
• Table 5: List of Molecular Targets Identified with Proteomics
• Table 6: Major Protein Sequencing and Mass Spectrometry Service Fee
• Table 7: Europe Protein Sequencing Market (by End User), $Million, 2022-2033
• Table 8: Europe Protein Sequencing Market (by Application), $Million, 2022-2033
• Table 9: Partnerships, Alliances, and Business Expansions (by Company), January 2021-September 2024